Clinical Study On Recovery Of Qizhi Tongluo Capsule In The Treatment Of Ischemic Stroke

Objective:To assess the clinical safety and effectivity of the Qizhitongluo Capsule in the recovery phase of ischemic stroke with qi deficiency and blood stasis syndrome.Methods:Adopting the clinical trial which is random include double and parallel contrast between positive drug and placebo.All the patients accorded with the recovery phase of ischemic stroke were divided into three groups randomly,Qizhitongluo Capsule group,Naoxintong Capsule group and placebo group.Effective indexes included: simplify Fugl-meyer movement function(upper limbs,lower limbs),the western aphasia battery(WAB),BI score and TCM syndrome score(qi deficiency and blood stasis).Blood Stasis.Safety indexes included: blood routine,urine routine,liver and kidney function and adverse reactions..Result: After 90 days of treatment Qizhitongluo Capsule can improve six effective indexes include:Lower limb motor function,upper limb dysfunction,movement disorders,AQ score,blood stasis,deficiency symptoms,although there is no statistical difference,but the trend is obvious.Clinical syndromes was improve obviously after 90 days and week 12 treatment between Qizhitongluo Capsule group and the placebo group(P = 0.014).Conclusion: Qizhitongluo Capsule is an effective and safe drug in treating the recovery phase of ischemic stroke.